GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Total Liabilities

PixarBio (PixarBio) Total Liabilities : $0.01 Mil (As of Sep. 2016)


View and export this data going back to 2016. Start your Free Trial

What is PixarBio Total Liabilities?

PixarBio's Total Liabilities for the quarter that ended in Sep. 2016 was $0.01 Mil.

PixarBio's quarterly Total Liabilities increased from Mar. 2016 ($0.13 Mil) to Jun. 2016 ($0.18 Mil) but then declined from Jun. 2016 ($0.18 Mil) to Sep. 2016 ($0.01 Mil).

PixarBio's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2014 ($0.03 Mil) and increased from Dec. 2014 ($0.03 Mil) to Dec. 2015 ($0.09 Mil).


PixarBio Total Liabilities Historical Data

The historical data trend for PixarBio's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio Total Liabilities Chart

PixarBio Annual Data
Trend Dec14 Dec15
Total Liabilities
0.03 0.09

PixarBio Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.09 0.13 0.18 0.01

PixarBio Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PixarBio's Total Liabilities for the fiscal year that ended in Dec. 2015 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.09+(0+0.001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=0.09

Total Liabilities=Total Assets (A: Dec. 2015 )-Total Equity (A: Dec. 2015 )
=0.369-0.278
=0.09

PixarBio's Total Liabilities for the quarter that ended in Sep. 2016 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.005+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=0.01

Total Liabilities=Total Assets (Q: Sep. 2016 )-Total Equity (Q: Sep. 2016 )
=0.362-0.357
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PixarBio Total Liabilities Related Terms

Thank you for viewing the detailed overview of PixarBio's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


PixarBio (PixarBio) Business Description

Traded in Other Exchanges
N/A
Address
200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.

PixarBio (PixarBio) Headlines